Anti-atherogenic and anti-ischemic potentials of Croton membranaceus observed during sub-chronic toxicity studies

BACKGROUND: Croton membranaceus (CM) is used for benign prostate hyperplasia treatment. OBJECTIVE: Sub-chronic toxicity studies are non-existent and provided the basis for this study. MATERIALS AND METHODS: 90 days oral administration of a low dose (LD) (30 mg/kg b. wt.), medium dose (MD) (150 mg/kg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Afriyie, Dan K., Asare, George A., Bugyei, Kwasi, Asiedu-Gyekye, Isaac, Gyan, Ben A., Adjei, Samuel, Addo, Phyllis, Sittie, Archibald, Nyarko, Alexander K.
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579014/
https://ncbi.nlm.nih.gov/pubmed/23598919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-8490.105640
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars